A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma. (Q42267589)
Jump to navigation
Jump to search
scientific article published on February 1981
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma. |
scientific article published on February 1981 |
Statements
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma (English)
R V Smalley
A A Bartolucci
G Hemstreet
1 February 1981